Lisa Earnheardt of Abbott and tennis legend Serena Williams on stage at CES 2026 [Image from Abbott on LinkedIn]
Some of medtech’s most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas last week.
The diabetes tech industry was well-represented, with glucose monitor makers and insulin pump developers making their presence felt. Meanwhile, a new EEG developer showcased its own earbud-based technology as well.
Other intriguing platforms on display included exoskeletons, sensors and laser-based medical devices.
Learn more about the medtech showcased at CES 2026:
(Read last year’s roundup here.)
Abbott showcases glucose biosensor tech
Abbott had an active CES, announcing new features for its own technology, new integrations and hosting a conversation with a sporting superstar.
The medtech giant unveiled a new feature called Libre Assist within its Libre app for continuous glucose monitoring (CGM). It aims to help people with diabetes better understand how the foods they eat affect their glucose levels. Abbott says the app differs from traditional food logging apps that only provide feedback after a meal is logged. This helps people make informed decisions before they eat.
The Libre Assist feature [Image courtesy of Abbott]
Abbott also entered into a partnership with Withings, adding its Lingo over-the-counter (OTC) CGM to the Withings app community. It aims to empower people to gain a more actionable understanding of their metabolism by continuously tracking glucose.
Finally, Lisa Earnhardt, EVP, Medical Devices at Abbott, spoke with tennis legend Serena Williams about using biowearables to reshape the way people understand their bodies.
Read about Libre Assist here.
Read about the Withings collaboration here.
See the conversation with Serena Williams here.
Insulet debuts at CES to highlight ‘liveable technology’
The Insulet Omnipod 5 was the first automated insulin delivery (AID) system cleared by the FDA for type 2 diabetes patients. [Photo courtesy of Insulet]
Automated insulin delivery (AID) technology developer Insulet made its first appearance at CES, showcasing its technology through an immersive booth experience, expert panel session and media demonstrations.
Insulet said the company’s CES debut centers around the showcasing of its “liveable technology.” It hopes to demonstrate its “philosophy for the future of connected health.” The company touts its intelligent systems that support daily life as digital health continues to accelerate.
Its interactive experience offered a hands-on journey into the automation of Omnipod, allowing attendees to connect with product specialists, hear stories from users and preview the next innovations in connected health.
Read the full story here.
Naox unveils FDA-cleared earbud-based EEG
Naox Link [Image courtesy of Naox Technologies]
Paris-based Naox Technologies said it won FDA clearance for its its wired electroencephelography (EEG) earphones, Naox Link.
The company said it takes EEG sensors to the next level by making them small enough to be earbuds. These wired EEG earphones, showcased at CES, would allow healthcare professionals to monitor brain activity remotely. In addition, the company’s Naox Wave is a consumer-focused set of earbuds that can be integrated with any true wireless stereo (TWS) earbuds.
Naox Technologies says its Naox Link will become the first in-ear EEG device for clinical use in home and healthcare environments. This use enables longer-duration acquisition of brain electrical activity.
Read the full story here.
Dexcom rolls into CES with new CEO
Glucose tracking with Stelo [Image courtesy of Dexcom]
New Dexcom CEO Jake Leach’s tenure began with appearances at CES in Las Vegas and will continue with an appearance at J.P. Morgan Healthcare Conference in San Francisco. At J.P. Morgan, he will deliver the opening presentation, presenting his vision for Dexcom and key future milestones.
Future developments include a redesigned app experience for the company’s Stelo over-the-counter (OTC) continuous glucose monitor (CGM). The company said it invested significantly in AI-enabled features to personalize insights and the user experience.
Following the initial launch of the company’s G7 15 Day CGM, Dexcom also expects to increase the availability of that product. It began shipping to pharmacies at the start of this month.
Read the full story here.
Other tech worth noting at CES 2026
- Digid unveiled its nanoscale temperature and force sensors at CES. The company’s patented printed electronics technology enables a sensor that is just 1µm long to be deposited on silicon, metal, polymer and other materials.
- Chinese exoskeleton maker RoboCT showcased its integrated exoskeleton devices with a cloud-based intelligence center, enabling real-time data monitoring, remote therapist oversight, and personalized training program adjustments.
- Wontech, a laser- and energy-based medtech developer, debuted two next-generation healthcare technologies at CES. One was a non-contact biometric monitoring solution and the other was a drug-free, non-surgical pain treatment platform that utilizes dual-wavelength laser therapy and electrical stimulation.
link